| 发明名称 |
Use of TAK1 Inhibitor to Achieve Glycemic Control in Mammals |
| 摘要 |
The present invention relates to use of inhibitors of TAK-1 for the production of pharmaceutical agents to achieve glycemic control in mammals and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. |
| 申请公布号 |
US2014154263(A1) |
申请公布日期 |
2014.06.05 |
| 申请号 |
US201314097967 |
申请日期 |
2013.12.05 |
| 申请人 |
Connexios Life Sciences Pvt. Ltd. |
发明人 |
Oommen Anup Mammen;Verma Mahesh Kumar;Bahadur Urvashi;Ramu Swapnika |
| 分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of using inhibitors of TAK-1 in preparing a medicament for therapy of diseases which are based on loss of glycemic control in mammals.
|
| 地址 |
Bangalore IN |
